Trade Summary

3 days ago, Sukhatme Mayukh, serving as President & CIO at Roivant Sciences Ltd. (ROIV), sold 335,174 shares at $36.88 per share, for a total transaction value of $12,360,813.41. Following this transaction, Sukhatme Mayukh now holds 18,630,739 shares of ROIV.

This sale represents a 1.77% decrease in Sukhatme Mayukh's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, August 19, 2026 and publicly disclosed via SEC Form 4 filing on Saturday, August 22, 2026 (accepted Aug 21, 9:00 PM ET), 3 days after the trade was made.

Roivant Sciences Ltd. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.